[PDF][PDF] Dysregulated expression of the nuclear exosome targeting complex component Rbm7 in nonhematopoietic cells licenses the development of fibrosis
K Fukushima, T Satoh, F Sugihara, Y Sato, T Okamoto… - Immunity, 2020 - cell.com
Fibrosis is an incurable disorder of unknown etiology. Segregated-nucleus-containing
atypical monocytes (SatMs) are critical for the development of fibrosis. Here we examined the …
atypical monocytes (SatMs) are critical for the development of fibrosis. Here we examined the …
Identification of an atypical monocyte and committed progenitor involved in fibrosis
…, M Ashihara, F Yamane, Y Minowa, K Fukushima… - Nature, 2017 - nature.com
Monocytes and macrophages comprise a variety of subsets with diverse functions 1 , 2 , 3 , 4
, 5 . It is thought that these cells play a crucial role in homeostasis of peripheral organs, key …
, 5 . It is thought that these cells play a crucial role in homeostasis of peripheral organs, key …
Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages
H Kanemaru, F Yamane, K Fukushima… - Proceedings of the …, 2017 - National Acad Sciences
The development of effective treatments against cancers is urgently needed, and the
accumulation of CD8 + T cells within tumors is especially important for cancer prognosis. Although …
accumulation of CD8 + T cells within tumors is especially important for cancer prognosis. Although …
[HTML][HTML] Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
…, H Hirata, S Nishida, K Miyake, K Fukushima… - Scientific reports, 2019 - nature.com
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
Tumor-derived semaphorin 4A improves PD-1–blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation
…, Y Nakanishi, Y Suga, T Morita, K Fukushima… - Science …, 2023 - science.org
Immune checkpoint inhibitors (ICIs) have caused revolutionary changes in cancer treatment,
but low response rates remain a challenge. Semaphorin 4A (Sema4A) modulates the …
but low response rates remain a challenge. Semaphorin 4A (Sema4A) modulates the …
[HTML][HTML] Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
…, T Niitsu, S Okamoto, K Tanaka, K Fukushima… - BMC infectious …, 2022 - Springer
Background The impact of SARS-CoV-2 infection on the gut fungal (mycobiota) and bacterial
(microbiota) communities has been elucidated individually. This study analyzed both gut …
(microbiota) communities has been elucidated individually. This study analyzed both gut …
[HTML][HTML] Host immune response and novel diagnostic approach to NTM infections
Y Abe, K Fukushima, Y Hosono, Y Matsumoto… - International Journal of …, 2020 - mdpi.com
The incidence and prevalence of non-tuberculous mycobacteria (NTM) infections are steadily
increasing worldwide, partially due to the increased incidence of immunocompromised …
increasing worldwide, partially due to the increased incidence of immunocompromised …
Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19
…, T Enomoto, R Hara, K Fukushima… - Respirology Case …, 2021 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19) can cause severe lymphopenia and respiratory failure
requiring prolonged invasive mechanical ventilation (MV). COVID‐19 patients with severe …
requiring prolonged invasive mechanical ventilation (MV). COVID‐19 patients with severe …
[HTML][HTML] Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients
…, T Ueda, M Tone, Y Naito, Y Suga, K Fukushima… - Scientific Reports, 2022 - nature.com
Anti-programmed cell death-1 (PD-1) therapy exerts beneficial effects in a limited population
of cancer patients. Therefore, more accurate diagnostics to predict the efficacy of anti-PD-1 …
of cancer patients. Therefore, more accurate diagnostics to predict the efficacy of anti-PD-1 …
[HTML][HTML] First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
K Fukushima, S Kitada, S Komukai, T Kuge… - Scientific Reports, 2021 - nature.com
The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the
standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). …
standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). …